Sally Moore

2.0k total citations
47 papers, 1.1k citations indexed

About

Sally Moore is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Sally Moore has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 20 papers in Hematology and 10 papers in Molecular Biology. Recurrent topics in Sally Moore's work include Multiple Myeloma Research and Treatments (18 papers), Cancer Treatment and Pharmacology (7 papers) and Peptidase Inhibition and Analysis (6 papers). Sally Moore is often cited by papers focused on Multiple Myeloma Research and Treatments (18 papers), Cancer Treatment and Pharmacology (7 papers) and Peptidase Inhibition and Analysis (6 papers). Sally Moore collaborates with scholars based in United Kingdom, United States and Australia. Sally Moore's co-authors include Karl Schurr, Rob Herbert, Anne M. Moseley, Ian Judson, Emma Gardiner, Philip Beale, Pascale Reidenberg, Paul Statkevich, David L. Cutler and Margaret Dugan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Sally Moore

41 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sally Moore United Kingdom 15 314 218 151 149 144 47 1.1k
Frédérique Gandjbakhch France 30 64 0.2× 73 0.3× 82 0.5× 105 0.7× 86 0.6× 70 2.8k
Gülce Askin United States 18 145 0.5× 222 1.0× 31 0.2× 71 0.5× 176 1.2× 58 1.2k
Richa Sharma United States 22 83 0.3× 222 1.0× 114 0.8× 88 0.6× 79 0.5× 69 1.2k
Duncan Porter United Kingdom 26 130 0.4× 75 0.3× 36 0.2× 129 0.9× 429 3.0× 65 2.7k
David J. McCarthy United States 23 76 0.2× 618 2.8× 159 1.1× 174 1.2× 106 0.7× 84 1.5k
Kristin Jochmans Belgium 21 73 0.2× 99 0.5× 55 0.4× 182 1.2× 101 0.7× 59 1.2k
Christian Simon Switzerland 25 564 1.8× 450 2.1× 18 0.1× 339 2.3× 34 0.2× 135 2.3k
Michele Santangelo Italy 23 506 1.6× 397 1.8× 13 0.1× 168 1.1× 41 0.3× 115 1.7k
Norman LaFrance United States 22 241 0.8× 197 0.9× 25 0.2× 87 0.6× 79 0.5× 60 1.3k
Christina Klose Germany 18 391 1.2× 366 1.7× 133 0.9× 92 0.6× 35 0.2× 45 1.4k

Countries citing papers authored by Sally Moore

Since Specialization
Citations

This map shows the geographic impact of Sally Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Moore more than expected).

Fields of papers citing papers by Sally Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Moore. The network helps show where Sally Moore may publish in the future.

Co-authorship network of co-authors of Sally Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Sally Moore. A scholar is included among the top collaborators of Sally Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally Moore. Sally Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moore, Sally, Christopher Parrish, Laura Miller, et al.. (2025). Assessment and treatment of frail patients living with multiple myeloma. A guideline on behalf of the UK Myeloma Research Alliance Frailty Group. British Journal of Haematology. 207(5). 1789–1801.
2.
Moore, Sally, et al.. (2024). Real‐world characteristics and outcomes of patients with multiple myeloma receiving second‐line treatment in England. SHILAP Revista de lepidopterología. 6(1). e1058–e1058. 1 indexed citations
3.
4.
Oliver, Rebecca, Daniel Augustine, D. Rees, et al.. (2024). A 16-week progressive exercise training intervention in treatment-naïve chronic lymphocytic leukaemia: a randomised-controlled pilot study. Frontiers in Oncology. 14. 1472551–1472551.
5.
Oliver, Rebecca, Daniel Augustine, Juliet C. Gray, et al.. (2024). A single bout of vigorous intensity exercise enhances the efficacy of rituximab against human chronic lymphocytic leukaemia B-cells ex vivo. Brain Behavior and Immunity. 118. 468–479. 2 indexed citations
6.
Agarwal, Gaurav, Lisa Ferguson, Jaimal Kothari, et al.. (2023). Targeted NGS Panel Guides Risk-Adapted Treatment Intention in Newly Diagnosed Myeloma Patients. Blood. 142(Supplement 1). 644–644. 1 indexed citations
7.
8.
Ramasamy, Karthik, Ross Sadler, Alison Turner, et al.. (2022). Immune response to COVID ‐19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T‐cell response. British Journal of Haematology. 197(3). 293–301. 14 indexed citations
9.
10.
Moore, Sally & Emma Gardiner. (2020). Point of care and intensive care lung ultrasound: A reference guide for practitioners during COVID-19. Radiography. 26(4). e297–e302. 55 indexed citations
11.
Sharpley, Faye, Grant Vallance, Toby A. Eyre, et al.. (2020). Treatment-free interval as an additional measure of efficacy in a large UK dataset of transplant ineligible myeloma patients. PLoS ONE. 15(2). e0229469–e0229469. 4 indexed citations
12.
Mahmood, Shameem, et al.. (2016). Diagnosing Light Chain Amyloidosis on Temporal Artery Biopsies for Suspected Giant Cell Arteritis. Journal of Neuro-Ophthalmology. 37(1). 34–39. 11 indexed citations
13.
Wong, Yuk-ki, et al.. (2015). Angina at Low heart rate And Risk of imminent Myocardial infarction (the ALARM study): a prospective, observational proof-of-concept study. BMC Cardiovascular Disorders. 15(1). 148–148. 1 indexed citations
14.
Smith, Nicola, Petra Mlčochová, Sarah A. Watters, et al.. (2015). Proof-of-Principle for Immune Control of Global HIV-1 Reactivation In Vivo. Clinical Infectious Diseases. 61(1). 120–128. 14 indexed citations
15.
Reiff, Andreas, Paul Krogstad, Sally Moore, et al.. (2009). Study of thymic size and function in children and adolescents with treatment refractory systemic sclerosis eligible for immunoablative therapy. Clinical Immunology. 133(3). 295–302. 6 indexed citations
16.
Maas, Mario, T. N. Hangartner, Giuliano Mariani, et al.. (2007). Recommendations for the assessment and monitoring of skeletal manifestations in children with Gaucher disease. Skeletal Radiology. 37(3). 185–188. 41 indexed citations
17.
Beale, Philip, Ian Judson, Sally Moore, et al.. (1999). Effect of gastric pH on the relative oral bioavailability and pharmacokinetics of temozolomide. Cancer Chemotherapy and Pharmacology. 44(5). 389–394. 31 indexed citations
18.
Beale, Philip, et al.. (1998). Phase I study of oral JM216 given twice daily. Cancer Chemotherapy and Pharmacology. 42(2). 142–148. 33 indexed citations
19.
Moore, Sally, et al.. (1993). Observation and analysis of hemiplegic gait: swing phase. Australian Journal of Physiotherapy. 39(4). 271–278. 108 indexed citations
20.
Moseley, Anne M., et al.. (1993). Observation and analysis of hemiplegic gait: stance phase. Australian Journal of Physiotherapy. 39(4). 259–267. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frédérique Gandjbakhch Breakdown of academic impact, for papers by Gülce Askin Breakdown of academic impact, for papers by Richa Sharma Breakdown of academic impact, for papers by Duncan Porter Breakdown of academic impact, for papers by David J. McCarthy Breakdown of academic impact, for papers by Kristin Jochmans Breakdown of academic impact, for papers by Christian Simon Breakdown of academic impact, for papers by Michele Santangelo Breakdown of academic impact, for papers by Norman LaFrance Breakdown of academic impact, for papers by Christina Klose
Rankless by CCL
2026